Holen Sie sich die Stockscreener-App
33.75
3.71%
-1.30
Handel nachbörslich:
33.75
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Mark R Munch reports multiple share sales (BRKR) under Rule 144 - Stock Titan
Bruker Corp (BRKR) Trading Down 3.62% on Mar 13 - GuruFocus
Bruker Makes Acquisitions; LeddarTech Added to Nasdaq: Week in Brief: 1/5/24 - Photonics Spectra
Natixis Advisors LLC Boosts Stock Position in Bruker Corporation $BRKR - MarketBeat
Bruker Corporation $BRKR Position Increased by Ceredex Value Advisors LLC - MarketBeat
Is Bruker (BRKR) Quietly Recasting Its Competitive Moat With Spatial Biology And Proteomics Upgrades? - simplywall.st
These analysts cut their forecasts on Bruker following Q4 results - MSN
Citigroup Inc. Sells 29,083 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corporation $BRKR Shares Acquired by Rhenman & Partners Asset Management AB - MarketBeat
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know - Finviz
RSI Alert: Bruker (BRKR) Now Oversold - Nasdaq
Research Tools & Consumables Stocks Q4 In Review: Bruker (NASDAQ:BRKR) Vs Peers - Yahoo Finance
Bruker Corp To Go Ex-Dividend On March 23rd, 2026 With 0.05 USD Dividend Per Share - 富途牛牛
BRKRP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BRKR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $49 - 富途牛牛
Artisan Partners Limited Partnership Invests $13.69 Million in Bruker Corporation $BRKR - MarketBeat
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Assessing Bruker (BRKR) Valuation After New Spatial Biology Platforms And Collaboration Updates - simplywall.st
BRKR PE Ratio & Valuation, Is BRKR Overvalued - Intellectia AI
Beyond the Balance Sheet: What SWOT Reveals About Bruker Corp (B - GuruFocus
Bruker (NASDAQ: BRKR) outlines 2025 business segments, risks and $2.57B backlog - Stock Titan
Bruker (BRKR): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics With the Launch of CellScape XR - 富途牛牛
Is Bruker (BRKR) Now Offering Value After A Prolonged Share Price Slump? - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages - MarketBeat
New Bruker tool targets 3,000-patient tumor study in spatial proteomics - Stock Titan
Is Bruker (BRKR) Now Attractive After A 21% One Year Share Price Decline? - simplywall.st
Reasons Why Bruker Corporation (BRKR) Appears So Attractive - Finviz
Inside Bruker and Noetik’s push toward 1B mapped human cells - Stock Titan
Bruker unveils spatial biology platforms at AGBT conference - Investing.com
Bruker unveils spatial biology platforms at AGBT conference By Investing.com - Investing.com Canada
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum - Yahoo Finance
Bruker announces board changes and declares quarterly dividend By Investing.com - Investing.com South Africa
Bruker announces board changes and declares quarterly dividend - Investing.com
Envestnet Asset Management Inc. Sells 43,490 Shares of Bruker Corporation $BRKR - MarketBeat
3D Protein Structure Analysis Market Report 2026 Featuring - GlobeNewswire
3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players - Yahoo Finance UK
The Top 5 Analyst Questions From Bruker's Q4 Earnings Call - Finviz
Nasdaq Analyst Becomes Optimistic; Check Out the Top 5 Upgrades for Thursday - Intellectia AI
The Top 5 Analyst Questions From Bruker’s Q4 Earnings Call - Yahoo Finance
Bruker (BRKR) executive exercises options and sells 2,000 shares - Stock Titan
Don't Overlook Bruker (BRKR) International Revenue Trends While Assessing the Stock - Yahoo Finance
Bruker Corp (BRKR) Shares Up 3.12% on Feb 17 - GuruFocus
Institutional Orbis investors report 9.8% Bruker (NASDAQ: BRKR) ownership stake - Stock Titan
Bruker's Q4 Earnings Lag Estimates, Margins Contract, Stock Down - Nasdaq
US$48.43: That's What Analysts Think Bruker Corporation (NASDAQ:BRKR) Is Worth After Its Latest Results - 富途牛牛
Analysts Have Been Trimming Their Bruker Corporation (NASDAQ:BRKR) Price Target After Its Latest Report - simplywall.st
Analysts Conflicted on These Healthcare Names: Crispr Therapeutics AG (CRSP) and Bruker (BRKR) - The Globe and Mail
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $35 to $49 - 富途牛牛
Can Bruker Corporation expand into new marketsPortfolio Gains Summary & Stepwise Trade Execution Plans - mfd.ru
A Look At Bruker (BRKR) Valuation After Mixed Earnings And Soft 2026 Growth Outlook - Yahoo Finance
Bruker’s 2025 Earnings Call Maps a Cautious Recovery - TipRanks
Forecasting The Future: 15 Analyst Projections For Bruker - Benzinga
Bruker (BRKR) Price Target Lowered by Citigroup, Rating Maintained | BRKR Stock News - GuruFocus
TD Cowen Issues Pessimistic Forecast for Bruker (NASDAQ:BRKR) Stock Price - MarketBeat
These Analysts Cut Their Forecasts On Bruker Following Q4 Results - Benzinga
Bruker (BRKR) Target Price Adjustment: Barclays Lowers Price Tar - GuruFocus
Bruker (BRKR) Is Down 8.6% After Mixed 2025 Results and Cautious 2026 Guidance Has The Bull Case Changed? - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Q4 2025 Earnings Call Transcript - Insider Monkey
0.66%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):